A Trial of SHR-1701 in Combination With and Without Famitinib Malate in Patients With Extensive Stage Small Cell Lung Cancer
Clinical trial NCT04884009 · UNKNOWN
Trial details
- NCT number
- NCT04884009
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-31
- Primary completion
- 2022-12-31
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.